期刊文献+

含RGD序列水蛭素嵌合抗栓剂的构建与表达 被引量:2

Construction and Expression of Chimeric Antithrombotics with Hirudin and RGD Sequence
下载PDF
导出
摘要 通过对水蛭素及一些含有精氨酸 甘氨酸 天冬氨酸 (RGD)序列的多肽类血小板聚集抑制剂结构与功能的分析 ,设计并构建了两个在水蛭素C端融合RGD序列的嵌合分子。嵌合体基因分别重组到表达载体pET 2 1a(+ )中并转化大肠杆菌BL2 1(DE3)。经限制酶消化和DNA序列分析 ,证明两种重组质粒与设计完全一致。由于RGD 水蛭素嵌合基因上游连接了金黄色葡萄球菌蛋白A(SPA)的信号肽序列 ,在IPTG诱导下两种嵌合分子都获得了分泌表达 ,表达产物主要集中在细胞周质空间。通过离子交换层析和凝胶过滤层析分别对两种嵌合体蛋白进行纯化 ,纯化产物在Tricine SDS PAGE中都显示为单一条带。活性分析结果表明两种嵌合体蛋白在保留水蛭素抗凝血酶活力的同时 ,还呈现抗血小板聚集活性。 Based on the structure and function analysis of hirudin,a potent thrombin inhibitor,and some platelet aggregation inhibitors,which contain the recognition sequence Arg Gly Asp(RGD)as their functional motif,two chimeric antithrombotic molecules were designed by introducing RGD sequence to hirudin C terminus.These chimera genes were constructed by PCR and inserted into the expression vector pET 21a(+),the constructs were confirmed by restriction enzyme digestion and DNA sequence analysis.These recombinant plasmids were transformed into E.coli strain BL21(DE3),and gene expression was induced by IPTG.The target proteins were directed into the periplasmic space by the staphylococcal protein A(SPA)signal sequence preceding the RGD hirudin gene.Using ion exchange chromatography and gel filtration chromatography,the chimera proteins were purified,and both of them showed a single band in Tricine SDS PAGE.The results of activity analysis suggested that these two chimera proteins not only have antithrombin activities,but gain platelet aggregation inhibitory activities as well.
出处 《北京大学学报(自然科学版)》 CAS CSCD 北大核心 2001年第4期490-495,共6页 Acta Scientiarum Naturalium Universitatis Pekinensis
基金 国家重点科技攻关 ( 96 C0 2 0 1 0 5 ) 北大 烟台发展科研开发基金资助项目
关键词 水蛭素 RGD序列 嵌合抗栓剂 血栓性疾病 抗凝血酶活力 嵌合体 构建 表达 hirudin RGD sequence chimeric antithrombotic
  • 相关文献

参考文献1

  • 1Madan M,Circulation,1998年,98卷,23期,2629页

同被引文献23

  • 1沈雳,陈少萍,蔡在龙,杨生生,秦永文.嵌合水蛭肽的构建与活性分析[J].中国生物化学与分子生物学报,2004,20(5):702-706. 被引量:4
  • 2宁保安,马茹,郑玉玲,高志贤,申博,姜永强.RGD-葡激酶突变体(K130T,K135R)的制备与活性分析[J].生物工程学报,2005,21(3):456-460. 被引量:5
  • 3Church FC,Phillips JE,Woods JL.Characterization of an Arg-Gly-Asp (RGD) and hirudin carboxyl terminus-containing synthetic peptides[J].Biol Chem,1991,266:11975.
  • 4Vanzyl WB,Pretorius GH,Hartmann M,et al.Production of a recombinant antithrombotic and fibrinolytic protein,PLATSAK,in Escherichia coli[J].Thromb Res,1997,88:419.
  • 5Ma YQ,Qin J,Plow EF.Platelet integrin alpha(Ⅱb) beta(3):activation mechanisms[J].J Thromb Haemost,2007,5 (7):1345-1352.
  • 6Zhang JG,Krajden OB,Kainthan RK,et al.Conjugation to hyperbranched polyglycerols improves RGD mediated inhibition of platelet function in vitro[J].Bioconjug Chem,2008,19(6):12412-12417.
  • 7Huang CL,Cheng JC,Stern A,et al.Disabled is a novel alphaⅡb-integrin-binding protein that negatively regulates platelet-fibrinogen interactions and platelet aggregation[J].J Cell Sci,2006,119(pt 21):4422-4430.
  • 8Pene S.Tirofiban therapy tips the scales after angioplasty[J].Inpharma Weekly,2008,1655:11-12.
  • 9Huang G,Zhou Z,Srinivasan R,et al.Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets[J].Biomaterials,2008,29(11):1676-1685.
  • 10Barre DE.Arginyl-glycyl-aspartic(RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the Ⅱb subunit of the fibrinogen (GPⅡb/Ⅲa) receptor[J].Thromb Res,2007,119(5):601-607.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部